Moldova vs Mus: Previously treated cases tested for RR-/MDR-TB (%)
Moldova
100.0%
in 2024
Mus
100.0%
in 2022
Moldova rank
1st
Mus rank
1st
Previously treated cases tested for RR-/MDR-TB (%) over time
- Moldova
- Mus
How they compare
Moldova currently reports 100.0% against 100.0% in Mus, a difference of 0.0%.
The two have swapped places 2 times across 18 shared years of data; in 2005 it was Mus ahead.
Moldova ranks 1st and Mus ranks 1st of 180 countries.
Mus has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Moldova | Mus | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 62.6% | 92.0% | 29.4% | Mus |
| 2010s | 63.6% | 96.0% | 32.4% | Mus |
| 2020s | 98.0% | 100.0% | 2.0% | Mus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Moldova or Mus?
- Moldova, at 100.0% against 100.0% in Mus as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Moldova and Mus?
- 0.0%, with Moldova ahead.
- How many years of comparable data are there for Moldova and Mus?
- 18 years are reported by both, from 2005 to 2022.
- How do Moldova and Mus rank globally for previously treated cases tested for rr-/mdr-tb?
- Moldova ranks 1st and Mus ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.